Virology & Antiviral Research (JVA) is a peer-reviewed Hybrid Open Access Scholarly Journal that is distributed internationally. The journal provides the choice of both open access and subscription mode of publication to the authors and publishes almost all types of write-ups like research articles, review, case reports, case study, commentary, letter to the editor, mini review, opinion, short communication, book review, editorials etc.
Journal of Virology & Antiviral features article on all aspects of viral structure and viral types, viral immunological studies like host-virus interaction, host defenses, replication and maturation studies of virus etc and different types of viral-associated diseases, viral oncology studies antiviral studies on both cancer causing diseases and normal viral diseases special references to HIV, hepatitis virus along with Antiviral drugs studies on validation, immunology impacts on the host and present scenario on viral structure, viral genetic, emergence of different types of viruses in the present scenario.
The authors can submit their manuscript through Editorial Manager System or Online submission. If the authors find any difficulty in submitting their manuscript, they can E-mail it to firstname.lastname@example.org.
The journal follows double-blind peer review process. Manuscripts submitted by authors will be evaluated on Editorial Manager® System by Editors & reviewers of particular expertise in the same field to ensure that the published articles are of high quality with accurate and reliable information & data, which reflect solid scholarship. Editors can manage the whole submission, review, revision and publishing process,however at least two independent reviewer's approval followed by the Editor decision is required for the acceptance of any citable manuscript.
AIDS research is a fundamental research in studying the prevention, cure and treatment, it also concentrate on the causative organism structure and rehabilitation.
Antiviral research is a broad classification of virus research which covers up the development of drugs vaccines, immunology impacts of the viral drugs on the host organism and also the immunotherapies of the plant and animal virus.
Anti-viral drugs are a broad classification of medication of viral infection which ability decreases the ability virus replication to reproduce, unlike the antibodies it never destroy pathogen instead of decrease or inhibit the development.
Clinical virology is a subdivision under viral methodology which deals with clinical aspects of virus-induced clinical conditions. It includes the study of resistance of viruses in treatment antiviral by viral genome sequencing and viral pathogenesis.
The word of hepatitis derived from the Greek word hepar means liver titis means inflammation. Hepatitis diseases second most deadly after the AIDS. Hepatitis is a viral which attacks the immune system of the liver which leads to the inflammation of the liver.
HIV virus is an causative organism of the worlds deadliest disease called AIDS. Human immunodeficiency virus is an retro virus which possess the RNA has a genetic material in the genome component.
Host defense is first line of defense against the very infection, it’s protect against which includes the natural barrier, nonspecific infection and specific response. During the pathogenesis which are two factors that is virulence of the virus and the susceptibility of the host.
Virus display show more specificity towards the host virus interaction virus interact with many cellular activities of the host cell to achieve the replication cycle that result host pathogen interaction between each other. There are many immunological impacts to study to understanding host virus interaction.
The old conventional method of antiviral technique is that to inhibiting the function of the RNA or DNA polymerase enzyme which are main sole for replication. The modern anti-viral technique is target to design viral protein or parts or protein that can be disabled.
RNA Interference Technology is a natural occurring phenomenon which results in silencing the gene function. In research protein which no longer impact in the genetic transfer. The phenomenon if the RNA interference technology in the viral treatment is to preventing or silencing the foreign gene for expressing towards the viral pathogenesis.
It is a broad branch of medical science which deals with the immunology impacts of the viral pathogenesis along with the host interaction. Viral immunology deals with immunology effects on the host-interaction.
Viral infection is a disease that can be caused by different kinds of viruses such as influenza virus which is best known. Most of the infection spread through the vectors , indirect mode or direct mode of transmission.
Viral genetics is study of heritable genes present in the particular which responsible for the viral infection such as genome structure replication and some protein which play important role in the viral pathogenesis.
Virus continually adjusts and interact the host environment through replication and pathogenesis. Both DNA and RNA infections encode multifunctional proteins that collaborate with and adjust host cell proteins. Viral proteomics is a newly emerging research in which the studying the viral protein structure and function of the protein.
It is also known as virotherapy in which using of non-pathogenic viruses which help in to deliver gene of interest or viral therapeutic genes in to the host cell without damaging the host cell or tissue.
Most of the viral infection hard to treat because it doesn’t have any vaccination and antibodies doesn’t show impact on viruses. In moment of infection treated with drugs by blocking the mode of replication by arresting the RNA polymerase or DNA polymerase enzymes which are main sole for the viral replication.
Viral vectors which are used as vehicle in the gene therapy which is physical inserts genes in to the host cell delivers the corrected gene in the process of gene therapy. Some of which are vector are adenovirus, alpha virus, herpes virus and vaccinia virus.
Virology & Antiviral Research is organizing & supporting held on Viral Infections, Outbreaks, Ebola and Control, September 18-20, 2017, Charlotte, North Carolina, USA with a theme "Novel and Innovative Therapeutic Techniques for Fighting Viral Diseases"
*2015 Journal Impact Factor was established by dividing the number of articles published in 2013 and 2014 with the number of times they are cited in 2015 based on Google search and the Scholar Citation Index database. If ‘X’ is the total number of articles published in 2013 and 2014, and ‘Y’ is the number of times these articles were cited in indexed journals during 2015 than, impact factor = Y/X